Praxis Precision Medicines, Inc. — Investor Relations & Filings
Filings indexed
458
across all filing types
Latest filing
2026-06-01
Regulatory Filings
Country
US
United States of America
Listing
US
PRAX
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company's methodology involves translating insights from genetic epilepsies into treatments for conditions characterized by neuronal excitation-inhibition imbalance. Praxis employs a genetics-focused approach, utilizing translational tools and patient-guided development strategies to advance its portfolio. The developmental pipeline includes several clinical-stage assets and numerous early-stage programs designed to address complex brain disorders.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-01 | English | |
| 8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-05-13 | English | |
| 10-Q - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-05-07 | English | |
| 8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-04-14 | English | |
| 10-K - PRAXIS PRECISION MEDICINES, INC. (0001689548) (Filer) | 2026-02-19 | English | |
| 8-K - PRAXIS PRECISION MEDICINES, INC. (0001689548) (Filer) | 2026-02-19 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47923543 | 8-K | 2026-06-01 | English | ||
| 45762232 | 8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-05-13 | English | ||
| 42975659 | 10-Q - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-05-07 | English | ||
| 34526963 | 8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-04-14 | English | ||
| 32896674 | 10-K - PRAXIS PRECISION MEDICINES, INC. (0001689548) (Filer) | 2026-02-19 | English | ||
| 32896673 | 8-K - PRAXIS PRECISION MEDICINES, INC. (0001689548) (Filer) | 2026-02-19 | English | ||
| 31313944 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31313940 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31313924 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31313936 | SCHEDULE 13G/A Filing | 2026-02-12 | English | ||
| 31313941 | 4 Filing | 2026-02-10 | English | ||
| 31313927 | 4 Filing | 2026-02-10 | English | ||
| 31313942 | SCHEDULE 13G Filing | 2026-02-05 | English | ||
| 12992957 | FORM 4 | 2026-01-14 | English | ||
| 12992959 | FORM 4 | 2026-01-14 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ernexa Therapeutics Inc.
Biopharmaceutical company developing cell therapies for can…
|
ERNA | US | Manufacturing |
|
ERYTECH Pharma S.A.
Develops red blood cell-based therapies for cancer and orph…
|
ERYP | FR | Manufacturing |
|
Esperion Therapeutics, Inc.
Develops and commercializes oral medicines to reduce cardio…
|
ESPR | US | Manufacturing |
|
ESSA Pharma Inc.
Develops drugs targeting the androgen receptor's N-terminal…
|
EPIX | US | Manufacturing |
|
Essex Bio-Technology Limited
Develops and manufactures biologic drugs using recombinant …
|
1061 | HK | Manufacturing |
|
Estrella Immunopharma, Inc.
Clinical-stage biopharma developing T-cell immunotherapies …
|
ESLA | US | Manufacturing |
|
Eton Pharmaceuticals, Inc.
Pharmaceutical company developing and commercializing treat…
|
ETON | US | Manufacturing |
|
EuBiologics Co., Ltd.
A biopharmaceutical company developing vaccines and offerin…
|
206650 | KR | Manufacturing |
|
Eupraxia Pharmaceuticals Inc.
Clinical-stage biotech developing targeted extended-release…
|
EPRX | CA | Manufacturing |
|
EUPRAXIA PHARMACEUTICALS INC.
Clinical-stage biotech developing locally delivered, extend…
|
EPRX | CA | Manufacturing |
Praxis Precision Medicines, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32153/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32153 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32153 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32153 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32153}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Praxis Precision Medicines, Inc. (id: 32153)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.